NR4A1 and breast carcinoma: Based on these markers, breast cancer can be divided into three major molecular subtypes: luminal-like (hormone receptor positive, no HER2 over-expression), HER2-enriched (HER2 over-expression), and triple negative (hormone receptor negative & no HER2 over-expression).